Td Waterhouse Canada Inc. Fsd Pharma Inc. Transaction History

Td Waterhouse Canada Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 13, 2023	BUY	$0.77 - $1.81 $7,699 - $18,098	9,999 Added 2096.23%	10,476 $16.4 Million
Q4 2022 Nov 13, 2023	BUY	$0.73 - $1.07 $0 - $1	1 Added 0.21%	477 $501,000
Q3 2022 Nov 13, 2023	SELL	$0.78 - $1.02 $60 - $79	-78 Reduced 14.08%	476 $533,000
Q2 2022 Nov 13, 2023	BUY	$0.78 - $1.1 $80 - $113	103 Added 22.84%	554 $550,000
Q1 2022 Nov 13, 2023	BUY	$0.82 - $1.1 $63 - $85	78 Added 20.91%	451 $523,000

Q4 2021 Nov 13, 2023	BUY	$0.96 - $1.63 $358 - $607	373 New	373 $518,000

Ticker HUGE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 38,218,100
Market Cap $5.73M
Description
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

Stay updated on Td Waterhouse Canada Inc. with notifications on news.